Multiple NASA missions captured images as an interstellar comet zoomed by Mars in October.

Astonishing interstellar comet captured in new images by NASA Mars missions

NASA released new images of the interstellar comet 3I/ATLAS — just the third cosmic visitor from elsewhere in the galaxy ever confirmed — on Wednesday.

NASA releases new photos of interstellar comet 3I/ATLAS

NASA unveiled close-up pictures on Wednesday of the interstellar comet that’s making a quick one-and-done tour of the solar system.  Discovered over the summer, the comet known as 3I/Atlas is only the third confirmed object to visit our corner of the cosmos from another star.  Three NASA spacecraft on and near the red planet zoomed in on the comet as it passed just 18 million miles (29 million kilometers) away, revealing a fuzzy white blob.

NASA unveils close-up pictures of the comet popping by from another star

Archaeologists have identified more than a dozen ancient canoes that Indigenous people apparently left behind in a sort of prehistoric parking lot along a Wisconsin lakeshore.  The Wisconsin Historical Society announced Wednesday that archaeologists have mapped the location of 16 canoes submerged in the lake bed of Lake Mendota in Madison.

Wisconsin archaeologists identify 16 ancient canoes in a prehistoric lake 'parking lot'

Ape ancestors and early humans likely kissed their friends and sexual partners, according to a new study.

Kissing is an ‘evolutionary conundrum.’ Scientists just mapped its unexpected origins

() -Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA ​medicines in the U., marking a major ‌step in strengthening the company's domestic production network.

Moderna to complete US mRNA manufacturing network with $140 million investment

(Reuters) -Pfizer and supplier Tris Pharma reached a $41.5 million settlement with Texas to ​resolve a lawsuit claiming they defrauded the state's Medicaid program ‌over alleged quality control lapses in a medicine to treat attention deficit hyperactivity disorder in ‌children.

Pfizer in $41.5 million settlement with Texas over ADHD drug for children

ZURICH () -Novartis will expand its operations in North Carolina and build a ​manufacturing hub there as part of a planned ‌$23 billion of U. infrastructure investment over the next ‌five years, the Swiss pharmaceuticals company said on Wednesday.

Novartis to build manufacturing hub in North Carolina, creating 700 jobs

(Reuters) -Merck said on Monday it expects a commercial opportunity exceeding $5 billion from ​Cidara Therapeutics' experimental flu drug, and does not anticipate ‌it to require a review by the U. CDC's vaccine advisory panel before ‌launch.

Merck sees over $5 billion opportunity in Cidara's experimental flu drug

The Danish drugmaker said it's cutting the price of Wegovy and Ozempic from $499 to $349 per month for some customers who buy the drugs directly.

Novo Nordisk slashes prices of popular weight loss and diabetes drugs

COPENHAGEN (Reuters) -Novo Nordisk said on Monday it would lower the U. price of its injectable Wegovy obesity drug and pledged to go "all in" on its upcoming oral weight-loss pill,​ as the firm races to claw back lost ground in the lucrative market.

Novo Nordisk cuts Wegovy price as CEO pledges to go 'all in' on weight loss pill

Comet 3I/ATLAS recently emerged from behind the glare of the sun to become visible to ground-based telescopes.

Watch interstellar comet 3I/ATLAS speed away from the sun in free telescope livestream on Nov. 16

Robert Hays, an industrial electronics salesman in Arkansas, thought he’d purchased conventional medical insurance. So did Essie Nath, 67, a retired cafeteria worker in Wyoming. So did Martin Liz, 47, a Key West chef. Each enrolled in the kind of private health insurance that Trump administration officials have promoted as an alternative to plans sold under Obamacare.Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. The difference betw

The cheap health insurance promoted by Trump officials has this catch

New versions of Cheetos and Doritos, without artificial flavors or dyes, will be sold in December.

Cheetos and Doritos to launch new versions without artificial dyes

The Food and Drug Administration said Friday it will add a new warning and other limitations to a gene therapy for Duchenne’s muscular dystrophy that's been linked to two patient deaths.  The infused therapy from Sarepta Therapeutics will carry a boxed warning — the most serious type — alerting doctors and patients to the risk of potentially fatal liver failure with the treatment, the FDA said in a release.  The one-time therapy, Elevidys, has been under FDA scrutiny since the company reported t

FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths

New Cheetos and Doritos will be free of artificial dyes

Doritos and Cheetos are getting a makeover.  PepsiCo said Thursday it’s launching toned-down versions of its bright orange snacks that won't have any artificial colors or flavors.  Doritos and Cheetos Simply NKD will hit store shelves on Dec. 1.

Doritos and Cheetos dial back the bright orange in new versions without artificial ingredients

By Kamal Choudhury and Christy Santhosh (Reuters) -The U. Food and Drug Administration on Thursday approved Kura Oncology and Japanese ​partner Kyowa Kirin's once-daily pill, Komzifti, to treat a ‌rare form of blood cancer that has returned or stopped responding to treatment.

US FDA approves Kura-Kyowa's blood cancer therapy

PepsiCo announced on Thursday that its Cheetos and Doritos brands will be offering "colorless" alternatives

Doritos and Cheetos debut 'NKD' options, without artificial colors or flavors

Germany's Federal Court of Justice (BGH) is set to rule on Thursday on claims by Wirecard shareholders in the insolvency of the former DAX company. The question at issue is whether aggrieved shareholders can claim damages from the insolvency estate as ordinary creditors or not.

Top German court to rule on claims by Wirecard shareholders

By Sneha S K and Sriparna Roy (Reuters) -Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes,​ including a potential sale, and warned it could launch a proxy fight if no progress ‌is made in the next four months. In a second letter to Novavax's board in less than a month, shared exclusively with ‌Reuters on Wednesday, Shah Capital said it has become "increasingly disenchanted" with the company's weak COVID-19 vaccine sales.

Shah Capital pushes for Novavax sale, warns of proxy fight

By Jonathan Stempel NEW YORK (Reuters) -Amazon.com was sued on Wednesday in a proposed class action saying the retailer subjects thousands of warehouse employees with disabilities to a "punitive"

Business

Moderna to complete US mRNA manufacturing network with $140 million investment

Pfizer in $41.5 million settlement with Texas over ADHD drug for children

Novartis to build manufacturing hub in North Carolina, creating 700 jobs

Merck sees over $5 billion opportunity in Cidara's experimental flu drug

Novo Nordisk slashes prices of popular weight loss and diabetes drugs

Novo Nordisk cuts Wegovy price as CEO pledges to go 'all in' on weight loss pill

Watch interstellar comet 3I/ATLAS speed away from the sun in free telescope livestream on Nov. 16

The cheap health insurance promoted by Trump officials has this catch

Cheetos and Doritos to launch new versions without artificial dyes

FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths

New Cheetos and Doritos will be free of artificial dyes

FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths

Doritos and Cheetos dial back the bright orange in new versions without artificial ingredients

US FDA approves Kura-Kyowa's blood cancer therapy

Doritos and Cheetos debut 'NKD' options, without artificial colors or flavors

Top German court to rule on claims by Wirecard shareholders

Shah Capital pushes for Novavax sale, warns of proxy fight

Amazon sued over 'punitive' handling of employee absences

Amazon sued over 'punitive' handling of employee absences